<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00925496</url>
  </required_header>
  <id_info>
    <org_study_id>D10054</org_study_id>
    <nct_id>NCT00925496</nct_id>
  </id_info>
  <brief_title>Patient Benefit From the New Modular Shoulder Prosthesis PROMOS</brief_title>
  <acronym>Promos</acronym>
  <official_title>Patient Benefit From the New Modular Shoulder Prosthesis PROMOS - a Multicentre Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Smith &amp; Nephew Orthopaedics AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Smith &amp; Nephew, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Overall study design:&#xD;
&#xD;
      This study is a prospective, non-randomized, multicenter postmarket clinical follow-up study&#xD;
      with two study arms using the two shoulder prosthesis PROMOS™ STANDARD (group A) and PROMOS&#xD;
      REVERSE™ (group B). The study will collect efficacy and safety data over 10 years.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary objective of the study:&#xD;
&#xD;
      The primary objective is to quantify patient benefit after primary total shoulder&#xD;
      arthroplasty with the modular PROMOS™ shoulder system in a multicenter cohort study (real&#xD;
      world approach). Patient benefit will be quantified using objective and validated subjective&#xD;
      measures of function, activities of daily living (ADL) and quality of life (QoL).&#xD;
&#xD;
      Secondary objectives:&#xD;
&#xD;
        -  Rate of implant related findings like radiological loosening of the glenoid and&#xD;
           complications like intraoperative stem fissures&#xD;
&#xD;
        -  Prosthesis survival at common time points, e.g. 5 and 10 years&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2009</start_date>
  <completion_date type="Actual">December 2019</completion_date>
  <primary_completion_date type="Actual">December 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Primary outcome measures: Patient benefit will be measured with the SPADI and Constant Murley score at the joint level, with the QuickDASH for the upper extremity and the SF-36 mental score as a generic tool.</measure>
    <time_frame>Preop / 6M / 1Y / 2Y / 5Y / 10Y</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Active and passive ROM and strength / Rate of implant related complications / Rate of implant related findings like radiological loosening of the glenoid / Prosthesis survival at common time points, e.g. 5 and 10 years</measure>
    <time_frame>Preop / 6M / 1Y / 2Y / 5Y / 10Y</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">155</enrollment>
  <condition>Primary or Secondary Omarthrosis of the Shoulder Joint</condition>
  <arm_group>
    <arm_group_label>Standard PROMOS prosthesis</arm_group_label>
    <description>Patients receiving a standard PROMOS prosthesis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Reverse PROMOS prosthesis</arm_group_label>
    <description>Patients receiving a reverse PROMOS prosthesis</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Primary care clinic&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Eligibility:&#xD;
&#xD;
          -  Ages eligible for study: minimal age of 18 years&#xD;
&#xD;
          -  Genders eligible for study: both&#xD;
&#xD;
          -  Accepts healthy volunteers: no&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Primary or secondary omarthrosis as an indication for primary total shoulder&#xD;
             arthroplasty&#xD;
&#xD;
          -  Massive rotator cuff rupture&#xD;
&#xD;
          -  Willing an able to give written informed consent to participate in the study including&#xD;
             follow-ups&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous ipsilateral shoulder arthroplasty (group A and B)&#xD;
&#xD;
          -  Late stage rotator cuff disease (only group A)&#xD;
&#xD;
          -  Acute shoulder trauma (group A and B)&#xD;
&#xD;
          -  General medical contraindication to surgery (group A and B)&#xD;
&#xD;
          -  Legal incompetence (group A and B)&#xD;
&#xD;
          -  Tumour / malignoma (group A and B)&#xD;
&#xD;
          -  Recent history of substance abuse (group A and B)&#xD;
&#xD;
          -  Any disease process that would preclude accurate evaluation (e.g. neuromuscular,&#xD;
             psychiatric or metabolic disorder) (group A and B)&#xD;
&#xD;
          -  Known hypersensitivity to the materials used (group A and B)&#xD;
&#xD;
          -  Bacterial infection at the time point of operation (group A and B)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hans-Kaspar Schwyzer, Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Schulthess Klinik</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Orthopaedische Praxis / Praxisklinik</name>
      <address>
        <city>Münster</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Schulthess Klinik</name>
      <address>
        <city>Zurich</city>
        <zip>8008</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>June 19, 2009</study_first_submitted>
  <study_first_submitted_qc>June 19, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 22, 2009</study_first_posted>
  <last_update_submitted>April 3, 2020</last_update_submitted>
  <last_update_submitted_qc>April 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Omarthrosis shoulder joint</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

